A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation
NCT00149981
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Organ Transplantation
Interventions
DRUG:
everolimus (RAD)
Sponsor
Novartis Pharmaceuticals